Weight Gain Management in Patients With Schizophrenia

Summary

Evaluate the efficacy of nizatidine in reducing/limiting weight gain in patients with schizophrenia who have been under treatment with olanzapine for at least two months and evaluate the treatment effects on the Eating Inventory, BPRS, number of treatment, emergent adverse events, changes in vital signs, laboratory results and extrapyramidal effects.

Timeline

Start

2003-02

Primary completion

—

Completion

2003-10

Drugs

Indications